Evidence map›Paper›PMID 37446610›Full record

ArticleMolecules (Basel, Switzerland)2023

Identifying, Quantifying, and Recovering a Sorbitol-Type Petrochemical Additive in Industrial Wastewater and Its Subsequent Application in a Polymeric Matrix as a Nucleating Agent.

Joaquín Hernández-Fernández, Esneyder Puello-Polo, Edgar Marquez

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joaquín Hernández-FernándezChemistry Program, Department of Natural and Exact Sciences, San Pablo Campus, University of Cartagena, Cartagena 130015, Colombia.ORCID 0000-0002-2330-8580
Esneyder Puello-PoloGroup de Investigación en Oxi/Hidrotratamiento Catalítico y Nuevos Materiales, Programa de Química-Ciencias Básicas, Universidad del Atlántico, Puerto Colombia 081001, Colombia.ORCID 0000-0002-0162-3619
Edgar MarquezGrupo de Investigaciones en Química y Biología, Departamento de Química y Biología, Facultad de Ciencias Básicas, Universidad del Norte, Carrera 51B, Km 5, Vía Puerto Colombia, Barranquilla 081007, Colombia.ORCID 0000-0002-7503-1528

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, polypropylene (PP) is highlighted using sorbitol-based clarifying agents since these agents are high quality, low cost, and work as a barrier against moisture, which makes PP ideal for packaging food, beverages, and medical products, among others. The use of analytical methods capable of recovering these additives in wastewater streams and then reusing them in the PP clarification stage represents an innovative methodology that makes a substantial contribution to the circular economy of the PP production industry. In this study, a method of extraction and recovery of the Millad NX 8000 was developed. The additive was recovered using GC-MS and extracted with an activated carbon column plus glass fiber, using an injection molded sample, obtaining a recovery rate greater than 96%. TGA, DSC, and FTIR were used to evaluate the recovered additive's glass transitions and purity. The thermal degradation of the recovered additive was found to be between 340 and 420 °C, with a melting temperature of 246 °C, adopting the same behavior as the pure additive. In FTIR, the characteristic absorption peak of Millad NX 8000 was observed at 1073 cm

Indexed as

SorbitolWastewaterPolymersPolypropylenesProduct PackagingPolymersPolypropylenesSorbitolWastewaterclarifying agentcrystallizationdegradationMillad NX 8000polypropylenepurityrecoverysolid phase extraction

Identifiers

PMID37446610
PMCPMC10343203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.